MPM BioImpact’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

MPM BioImpact’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,214,662	Closed	-$47.8M	–	37
2023 Q2	$47.8M	Buy	1,214,662 +168,971	+16%	+$5.96M	9.62%	2
2023 Q1	$25.4M	Sell	1,045,691 -13,997	-1%	-$306K	6.61%	3
2022 Q4	$22.7M	Buy	1,059,688 +9,688	+0.9%	+$207K	5.89%	5
2022 Q3	$18.8M	Buy	+1,050,000	New	+$13.8M	4.46%	8

MPM BioImpact's ISEE Position: Q3 2023 in Review

MPM BioImpact sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,214,662 shares — an estimated $47.8M sold.

MPM BioImpact first reported a position in ISEE in Q3 2022 and held it in 4 quarters. The position peaked at $47.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

MPM BioImpact reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
MPM BioImpact sold 1,214,662 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $47.8M.
MPM BioImpact first reported a position in IVERIC bio, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
MPM BioImpact's IVERIC bio, Inc. Common Stock position peaked at $47.8M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on MPM BioImpact's 13F filing for Q3 2023, filed 14 Nov 2023.